- Home
- RVMD vs BEN Comparison
RVMD vs BEN Comparison
Compare RVMD & BEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RVMD
- BEN
- Stock Information
- Founded
- RVMD 2014
- BEN 1947
- Country
- RVMD United States
- BEN United States
- Employees
- RVMD N/A
- BEN N/A
- Industry
- RVMD Biotechnology: Biological Products (No Diagnostic Substances)
- BEN Investment Managers
- Sector
- RVMD Health Care
- BEN Finance
- Exchange
- RVMD Nasdaq
- BEN Nasdaq
- Market Cap
- RVMD 10.2B
- BEN 10.7B
- IPO Year
- RVMD 2020
- BEN N/A
- Fundamental
- Price
- RVMD $57.03
- BEN $21.79
- Analyst Decision
- RVMD Strong Buy
- BEN Sell
- Analyst Count
- RVMD 13
- BEN 13
- Target Price
- RVMD $57.00
- BEN $21.87
- AVG Volume (30 Days)
- RVMD 1.6M
- BEN 4.2M
- Earning Date
- RVMD 11-06-2024
- BEN 11-04-2024
- Dividend Yield
- RVMD N/A
- BEN 5.78%
- EPS Growth
- RVMD N/A
- BEN N/A
- EPS
- RVMD N/A
- BEN 0.85
- Revenue
- RVMD $742,000.00
- BEN $8,478,000,000.00
- Revenue This Year
- RVMD N/A
- BEN N/A
- Revenue Next Year
- RVMD $300.00
- BEN $3.66
- P/E Ratio
- RVMD N/A
- BEN $25.32
- Revenue Growth
- RVMD N/A
- BEN 8.01
- 52 Week Low
- RVMD $20.86
- BEN $18.95
- 52 Week High
- RVMD $62.40
- BEN $30.32
- Technical
- Relative Strength Index (RSI)
- RVMD 61.89
- BEN 59.28
- Support Level
- RVMD $53.69
- BEN $21.40
- Resistance Level
- RVMD $62.40
- BEN $21.93
- Average True Range (ATR)
- RVMD 2.10
- BEN 0.60
- MACD
- RVMD -0.35
- BEN 0.03
- Stochastic Oscillator
- RVMD 49.83
- BEN 87.73
About RVMD Revolution Medicines Inc.
Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways. The company's products includes RMC-4630, a SHP2 inhibitor, RAS(ON) portfolio, and SOS1 and 4EBP1/mTORC1 programs.
About BEN Franklin Resources Inc.
Franklin Resources provides investment services for individual and institutional investors. At the end of August 2024, Franklin had $1.681 trillion in managed assets, composed primarily of equity (36%), fixed-income (34%), multi-asset/balanced (10%) funds, alternatives (15%) and money market funds (5%). Distribution tends to be weighted equally between retail investors (52% of AUM) and institutional accounts (46%), with high-net-worth clients accounting for the remainder. Franklin is one of the more global of the US-based asset managers we cover, with 30% of its assets under management invested in global/international strategies and just as much sourced from clients domiciled outside the United States.